People today want to be in control of their health at every life stage. And their needs are more complex and expectations higher than ever. With our scientifically-researched and clinically-tested biosolutions for a stronger body and mind, they can navigate to better lifelong health. Our portfolio is manufactured at scale in-house and includes HMOs, probiotics, enzymes, novel vitamins, proteins and many other biosolutions to help you meet people’s complex needs. In December 2022, Chr. Hansen and Novozymes entered into an agreement to create a leading global biosolutions partner by combining the two companies. The goal was to unleash the full potential of biological solutions and generate significant value for all stakeholders and society. The combination was completed in January 2024 and Novonesis was born.
Novonesis
